ClinConnect ClinConnect Logo
Search / Trial NCT06144112

Fibrinogen Concentrates Versus Cryoprecipitate in Liver Transplant Surgery

Launched by KONKUK UNIVERSITY MEDICAL CENTER · Nov 16, 2023

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Hypofirinogenemia Coagulopathy Fibrinogen Cryoprecipitate Liver Transplantation Lyophilized Factor Concentrates

ClinConnect Summary

This clinical trial is studying two different treatments used to help manage bleeding during liver transplantation surgery. The goal is to find out whether using Prothrombin Complex Concentrate (PCC) or Fresh Frozen Plasma (FFP) helps stop bleeding more quickly and effectively. This is important because controlling bleeding can improve the safety and success of liver transplant surgeries.

To participate in this trial, individuals must be adults aged between 18 and 65 years who have liver disease and are scheduled for a liver transplant. The study is currently not recruiting participants, but when it begins, those who qualify will receive one of the two treatments during their surgery. Throughout the trial, participants will be monitored to see how well each treatment works in managing bleeding. Your involvement could help improve future care for patients undergoing liver transplants!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Liver disease undergoing Liver transplantation
  • Exclusion Criteria:
  • -

About Konkuk University Medical Center

Konkuk University Medical Center is a leading healthcare institution located in Seoul, South Korea, recognized for its commitment to advancing medical research and improving patient care. As a clinical trial sponsor, the center leverages its state-of-the-art facilities and multidisciplinary expertise to conduct innovative research that addresses critical health challenges. With a focus on collaboration and ethical standards, Konkuk University Medical Center aims to contribute significantly to the development of new treatments and therapies, enhancing the overall quality of healthcare both locally and globally.

Locations

Seoul, , Korea, Republic Of

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported